Bank of New York Mellon
TGX

Bank of New York Mellon’s THERAGENICS CORP TGX Stock Holding History

Bank of New York Mellon’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-42,716
Closed -$93K – 4316
2013
Q3 		$93K Buy
42,716
+40
+0.1% +$85 ﹤0.01% 3971
2013
Q2 		$88K Buy
+42,676
New +$76.4K ﹤0.01% 3957

Bank of New York Mellon's TGX Position: Q4 2013 in Review

Bank of New York Mellon sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 42,716 shares — an estimated $93K sold.

Bank of New York Mellon first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $93K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Bank of New York Mellon reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Bank of New York Mellon sold 42,716 THERAGENICS CORP shares in Q4 2013, an estimated $93K.
  • Bank of New York Mellon first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Bank of New York Mellon's THERAGENICS CORP position peaked at $93K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Bank of New York Mellon's 13F filing for Q4 2013, filed 12 Feb 2014.